It should also be noted that according to clinical data, full 5-HT1A blockade neither enhances nor cancels the antidepressant effect of fluoxetine in MDD patients [139], suggesting the involvement of other 5-HT receptors (e.g., 5-HT4 receptor) [151]. This evidence concerns the gene HTR1A and major depressive disorder.